"10.1371_journal.pmed.0040023","plos medicine","2007-01-30T00:00:00Z","Chantal Baron; Roland Somogyi; Larry D Greller; Vincent Rineau; Peter Wilkinson; Carolyn R Cho; Mark J Cameron; David J Kelvin; Pierre Chagnon; Denis-Claude Roy; Lambert Busque; Rafick-Pierre Sékaly; Claude Perreault","Institute of Research in Immunology and Cancer, University of Montreal, Montreal, Quebec, Canada; Department of Medicine, University of Montreal, Montreal, Quebec, Canada; Division of Hematology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada; Biosystemix Limited, Sydenham, Ontario, Canada; Lady Davis Institute for Medical Research, Montreal, Quebec, Canada; Toronto General Research Institute, Toronto, Ontario, Canada; Centre de Recherche du Centre Hospitalier de lUniversité de Montréal, Montréal, Quebec, Canada","CB and CP designed the study. DCR and LB enrolled patients. RS, LDG, DCR, LB, and RPS gave comments at each stage. CB and VR purified T cell subsets and extracted RNA. RS, LDG, and CRC were involved in the conception and design of the mathematical model and statistical analysis of model results. MJC and DJK supervised RNA amplification and microarray hybridization. PW and MJC performed microarray data preprocessing. CB and PC performed and analyzed real-time RT-PCR. CB, RS, LDG, and CP drafted the manuscript. VR, PW, CRC, MJC, DJK, PC, DCR, LB, and RPS reviewed the work and edited the manuscript.","The University of Montreal has filed a provisional patent application entitled Assessment and reduction of risk of graft-versus-host disease that is based on the present work. CB, RS, LDG, and CP are listed as co-inventors on that provisional patent application.","2007","01","Chantal Baron","CB",13,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
